Healthy Living/WellnessFDA Panel Pushes For Approval Of Amgen's Cholesterol-Lowering Drug Repatha Members of an FDA panel urge the agency to approve Repatha. The drug made by Amgen is said to significantly lower LDL or "bad" cholesterol.by Rina Marie Doctor
Healthy Living/WellnessNew Drugs Can Lower Cholesterol But Price Might Give You A Big Headache - $10,000 A Yearby Rhodi Lee
Healthy Living/WellnessStudy Claims Amgen's Kyprolis More Effective Than Takeda's Velcadeby Dianne Depra
Healthy Living/WellnessAmgen's brodalumab improves psoriatic arthritis signs and symptoms in Phase 2 studyby Anu Passary
Healthy Living/WellnessNew experimental cholesterol drug by Amgen may be better than Lipitorby Rhodi Lee
Healthy Living/WellnessGene mutation that can reduce risk of Type 2 diabetes gets drugmakers' attentionby Rhodilee Jean Dolor